KERALA AYURVEDA
Back to Cashflow Statement
|
KERALA AYURVEDA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-9.48 Cr | ₹18 Cr | ₹-1.14 Cr | ₹-13 Cr | ₹6.20 Cr |
What is the latest Cash Flow from Financing Activities ratio of KERALA AYURVEDA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-9.48 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹-1.14 Cr |
| Mar2022 | ₹-13 Cr |
| Mar2021 | ₹6.20 Cr |
How is Cash Flow from Financing Activities of KERALA AYURVEDA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-9.48 Cr | Negative | |
| Mar2024 | ₹18 Cr | Positive | |
| Mar2023 | ₹-1.14 Cr | Negative | |
| Mar2022 | ₹-13 Cr | Negative | |
| Mar2021 | ₹6.20 Cr | - | |
Compare Cash Flow from Financing Activities of peers of KERALA AYURVEDA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KERALA AYURVEDA | ₹244.1 Cr | -8.1% | -12.1% | -49.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,909.0 Cr | -2.4% | 3% | 9.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹173,930.0 Cr | -3.3% | 3.5% | 4.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹147,181.0 Cr | -2% | 5% | 43.1% | Stock Analytics | |
| CIPLA | ₹112,353.0 Cr | -0% | 6.9% | -4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,608.0 Cr | -0.3% | -3.8% | 7.3% | Stock Analytics | |
KERALA AYURVEDA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KERALA AYURVEDA | -8.1% |
-12.1% |
-49.1% |
| SENSEX | -1.5% |
-3.4% |
-9.1% |
You may also like the below Video Courses